Author： Seltzer Ben
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.24, Iss.11, 2007-01, pp. : 881-890
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Long-Term Cholinesterase Inhibitor Treatment of Alzheimers Disease
CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. :
Access to resources
Recommend
Is current therapy for non-ST-elevation MI justified?
Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. :
Compulsory licensing of pharmaceuticals justified?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 389, 2002-01 ,pp. :
Cholinesterase Inhibitors in Alzheimer's Disease: Are they Worth the Cost?
CNS Drugs, Vol. 11, Iss. 3, 1999-03 ,pp. :
New anticancer drug costs justified?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 392, 2002-01 ,pp. :